NICE

1 Pharma Receiving Nice News (NVS)

1 Pharma Receiving Nice News (NVS)

Motley Fool

NICE reverses position on new use for Novartis' Lucentis

NICE reverses position on new use for Novartis' Lucentis

Fierce Pharma

NICE turns down Avastin for breast cancer

NICE turns down Avastin for breast cancer

Fierce Pharma

U.K. report says NICE drags its feet on drug approvals

U.K. report says NICE drags its feet on drug approvals

Fierce Pharma

NICE sticks with 'no' for GSK's Tyverb/Roche's Herceptin

NICE sticks with 'no' for GSK's Tyverb/Roche's Herceptin

Pharma Times, UK

Merck Asked by U.K. Agency for More Tests of Smoker’s Cough Drug

Merck Asked by U.K. Agency for More Tests of Smoker’s Cough Drug

Bloomberg

Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency

Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency

Bloomberg

News

Pfizer, Shire, Novartis Alzheimer’s Drugs Win U.K. NICE Backing

Bloomberg

News

NICE may bless off-label Avastin use in eyes

Fierce Pharma

News

This NICE Deal Could Foreshadow 2011

Motley Fool